Anika Therapeutics Inc (ANIK) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Anika Therapeutics Inc   (NASDAQ: ANIK)
 

Anika Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Anika Therapeutics Inc 's inventory turnover ratio sequentially decreased to 2.14 in the second quarter 2026, otherwise the ratio remained above the average, as ANIK's markets remain strong.Anika Therapeutics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 171 days, from 142 days, in the Mar 31 2026 quarter.

Within Healthcare sector 185 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1382, from total ranking in the first quarter 2026 at 1521.

ANIK Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Anika Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?




ANIK Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 68.8 % 7.04 % -21.09 % -58.91 % -67.12 %
Y / Y Cost of Sales Growth -12.57 % -9.09 % - -67.57 % -7.14 %
Inventory Turnover Ratio (TTM) 2.14 2.57 2.67 0.62 1.46
ANIK's Total Ranking # 1382 # 1521 # 1963 # 1784 # 1883
Average inventory processing period 170 142 137 589 250
Seq. Inventory Growth 25.08 % 21.56 % 15.37 % -3.77 % -20.69 %
Seq. Cost of Sales Growth 13.66 % -23.08 % 8.33 % -7.69 % 18.18 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 79
Healthcare Sector # 186
Overall Market # 1382

Inventory Turnover Ratio Statistics
High Average Low
3.31 1.69 0.62
(Jun 30 2012)   (Sep 30 2025)




Financial Statements
Anika Therapeutics Inc 's Inventories $ 29 Millions Visit ANIK's Balance sheet
Anika Therapeutics Inc 's Cost of Revenues TTM $ 46 Millions Visit ANIK's Income Statement
What are ANIK's Sales? Visit ANIK's Sales by Segment

Other Inventory Turnover Ratios
Anika Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ANIK's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ANIK's Competitors
Inventory Turnover Ratio for ANIK's Suppliers
Inventory Turnover Ratio for ANIK's Customers

You may also want to know
ANIK's Sales Growth Rates ANIK's Pe Price to earnings ratio ANIK's Receivables Turnover Ratio ANIK's Stock Quote
ANIK's Net Income Growth Rates ANIK's Ps Price to Sales ratio ANIK's Sales per Employee ANIK's Asset Turnover Ratio
ANIK's Net Margin ANIK's Pb Price to Book ratio ANIK's Financial Strength Ratios ANIK's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions
Zai Lab Limited  3.39 $ 195.542  Millions$ 58  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
Evolus Inc   3.37 $ 105.904  Millions$ 31  Millions

Date modified: 2026-09-08T16:32:07+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.